The CBA Competition Law and Foreign Investment Review Section’s Reviewable Matters/Unilateral Conduct Committee presents:

Lessons from JAMP/Janssen: Exploring the Competition Tribunal’s Decision to Deny Leave for Abuse of Dominance

February 06, 2025 | 12:00 PM to 1:00 PM Eastern
Online (Zoom)

The Competition Tribunal recently published its decision to dismiss JAMP Pharma Corporation's application for leave to bring an abuse of dominance application against Janssen Inc. Join our panelists as they unpack the Competition Tribunal’s first application for leave decision following the Competition Act's 2022 amendments expanding private access to include abuse of dominance. This brown bag will explore the Competition Tribunal's evidentiary findings, the evolving leave test for abuse of dominance, and the forthcoming June 2025 amendments to the application for leave test.

Moderator

Madison Bruno, Baker McKenzie 

Speakers

James Gotowiec, Torys

Katherine Kay, Stikeman Elliott

Donald Houston, Competition Bureau Legal Services

Kevin Hong, Competition Bureau Legal Services